50.83
-5.66%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 107.04 86.62 77.67 23.58% 37.81%
EBITDA 11.01 11.50 5.05 -4.25% 117.93%
Op. profit margin(%) 9.01 10.14 3.46 -11.07% 160.82%
Net Profit 5.59 5.88 2.62 -4.96% 113.37%
EPS 1.61 1.69 0.75 -4.73% 113.81%
* Consolidated data
352.70
-1.81%
Gujarat Themis reports Q2FY27 unaudited results and notes Company Secretary resignation
BSE India
Gujarat Themis board approves unaudited standalone and consolidated financial results for the quarter and half-year ended September 2026. The results include a limited review report submitted by the statutory auditors. Additionally, the board notes the resignation of Mr. Vineet Gawankar from the position of Company Secretary, effective November 30, 2026.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 47.46 43.79 42.35 8.37% 12.06%
EBITDA 21.40 20.93 21.76 2.29% -1.63%
Op. profit margin(%) 37.36 47.48 49.46 -21.32% -24.46%
Net Profit 8.47 11.07 14.26 -23.50% -40.65%
EPS 0.72 1.02 1.31 -29.41% -45.04%
* Standalone data
Sree Rayalaseema Hi-Strength Hypo approves unaudited financial results for Q2FY27 and H1FY27
BSE India
Sree Rayalaseema Hi-Strength Hypo approves its standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2026. The filing includes the limited review reports for both standalone and consolidated performance periods. The announcement focuses on the formal submission of these financial results to the stock exchanges.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 246.41 210.95 182.39 16.81% 35.10%
EBITDA 46.49 36.21 34.05 28.39% 36.53%
Op. profit margin(%) 14.29 14.16 14.78 0.94% -3.30%
Net Profit 32.70 24.73 23.29 32.22% 40.39%
EPS 19.18 14.54 13.57 31.91% 41.34%
* Consolidated data
Fruition Venture board approves unaudited standalone financial results for Q2FY27 and H1FY27
BSE India
Fruition Venture's board of directors approves the unaudited standalone financial results for the quarter and half year ended September 30, 2026. The announcement includes the limited review reports from statutory auditors and a disclosure statement regarding deviations in proceeds from a preferential issue warrant allotment. No specific revenue or profit figures are provided in the announcement text.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 1.04 1.25 1.01 -16.56% 3.15%
EBITDA 0.03 0.03 0.09 3.41% -61.74%
Op. profit margin(%) 3.19 2.30 8.59 38.63% -62.88%
Net Profit -0.07 -0.05 0.03 -28.02% -359.06%
EPS -0.14 -0.11 0.06 -30.00% -326.98%
* Standalone data
Source Natural Foods board approves unaudited financial results for Q2FY27 and H1FY27
BSE India
Source Natural Foods and Herbal Supplements Limited board of directors approves the unaudited financial results for the quarter and half year ended September 30, 2026. The announcement includes both standalone and consolidated financial statements accompanied by a limited review report from the statutory auditor. The filing confirms the completion of the review process for the period, though specific revenue and profit figures are not disclosed in this notice.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 22.25 21.42 16.95 3.85% 31.24%
EBITDA 1.50 1.37 1.36 9.48% 10.42%
Op. profit margin(%) 6.51 5.55 8.03 17.28% -18.87%
Net Profit 0.77 0.74 0.70 4.55% 10.07%
EPS 1.20 1.15 1.09 4.35% 10.09%
* Standalone data
590.30
-1.22%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.81 0.68 0.83 19.01% -2.53%
EBITDA -0.23 -0.06 -0.16 -262.40% -41.03%
Op. profit margin(%) -27.97 -24.61 -19.28 -13.65% -45.08%
Net Profit -0.25 -0.09 -0.20 -191.72% -22.52%
EPS -0.48 -0.16 -0.39 -200.00% -23.08%
* Standalone data
Garnet Construction reports negative revenue operations from revenue operations for Q2FY27
BSE India
Garnet Construction reports a significant decline in operational performance for Q2FY27, with revenue operations from operations falling to a negative Rs 12.92 crore YoY. The company faces substantial headwinds as it struggles to maintain positive revenue flow during the quarter ended September 30, 2026. The unaudited results reflect a contraction in core business activities compared to the previous period. Further financial details remain limited in the current disclosure.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.52 -0.13 16.28 501.01% -96.82%
EBITDA -0.96 -0.74 8.97 -30.29% -110.69%
Op. profit margin(%) -187.99 577.79 54.96 -132.54% -442.04%
Net Profit -1.37 -1.04 6.53 -31.74% -120.93%
EPS -0.98 -0.75 4.70 -30.67% -120.86%
* Standalone data
56.77
4.99%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 62.80 55.23 38.15 13.71% 64.62%
EBITDA 16.70 10.71 5.74 55.85% 190.94%
Op. profit margin(%) 26.59 19.40 14.99 37.07% 77.33%
Net Profit 12.10 7.50 3.92 61.20% 208.49%
EPS 1.04 0.64 0.34 62.50% 205.88%
* Standalone data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 6.93 7.30 5.12 -4.99% 35.41%
EBITDA 0.38 0.65 0.73 -41.62% -48.33%
Op. profit margin(%) 3.45 5.18 13.58 -33.38% -74.58%
Net Profit 0.06 0.22 0.01 -74.32% 537.08%
EPS 0.11 0.44 0.02 -75.00% 450.00%
* Standalone data